Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $3.7B | -- | -- | -$0.57 | -- |
| 11/06/2025 | Q3 | $3.7B | $3.6B | -$44.37 | -$1.22 | -$43.15 |
| 08/01/2025 | Q2 | $3.8B | $3.7B | -$1.06 | -$1.04 | -$0.02 |
| 05/08/2025 | Q1 | $3.9B | $3.9B | -$0.71 | -$0.87 | $0.16 |
| 02/27/2025 | Q4 | $3.9B | $4B | $1.17 | -$0.49 | $1.67 |
| 11/12/2024 | Q3 | $3.9B | $3.9B | -$0.52 | -$0.30 | -$0.22 |
| 08/09/2024 | Q2 | $4B | $4B | -$0.76 | -$0.08 | -$0.68 |
| 05/08/2024 | Q1 | $4.1B | $4B | -$0.40 | -$0.08 | -$0.31 |
| 02/29/2024 | Q4 | $4.1B | $15.7B | -$6.80 | $0.04 | -$6.85 |
| 11/06/2023 | Q3 | -- | $4.1B | -$0.51 | -- | -- |
| 08/08/2023 | Q2 | -- | $4.4B | $0.69 | -- | -- |
| 05/09/2023 | Q1 | -- | $4.4B | $0.82 | -- | -- |
| 02/23/2023 | Q4 | -- | $499.9M | $0.59 | -- | -- |
| 11/03/2022 | Q3 | -- | $497.4M | $0.27 | -- | -- |
| 08/04/2022 | Q2 | -- | $499.3M | $0.16 | -- | -- |
| 05/05/2022 | Q1 | -- | $501.5M | $1.06 | -- | -- |
| 02/24/2022 | Q4 | -- | $498.6M | -$0.88 | -- | -- |
| 11/09/2021 | Q3 | -- | $504.7M | $0.38 | -- | -- |
| 08/03/2021 | Q2 | -- | $499.8M | $0.41 | -- | -- |
| 05/06/2021 | Q1 | -- | $482.6M | $0.84 | -- | -- |
| 02/23/2021 | Q4 | -- | $489.3M | $0.00 | -- | -- |
| 11/05/2020 | Q3 | -- | $473.5M | $0.26 | -- | -- |
| 08/06/2020 | Q2 | -- | $459.5M | -$0.12 | -- | -- |
| 05/07/2020 | Q1 | -- | $465.7M | -$0.56 | -- | -- |
| 02/20/2020 | Q4 | -- | $499M | -$0.54 | -- | -- |
| 11/07/2019 | Q3 | -- | $472.3M | -$0.19 | -- | -- |
| 08/08/2019 | Q2 | -- | $460.4M | -$0.06 | -- | -- |
| 05/08/2019 | Q1 | -- | $454.4M | $0.15 | -- | -- |
| 02/21/2019 | Q4 | -- | $454M | -$1.17 | -- | -- |
| 11/08/2018 | Q3 | -- | $456.3M | $0.17 | -- | -- |
| 08/07/2018 | Q2 | -- | $526M | $0.80 | -- | -- |
| 05/10/2018 | Q1 | -- | $501.8M | -$0.22 | -- | -- |
| 02/22/2018 | Q4 | -- | $506M | $3.23 | -- | -- |
| 11/08/2017 | Q3 | -- | $481.2M | $0.36 | -- | -- |
| 08/09/2017 | Q2 | -- | $465.1M | $0.07 | -- | -- |
| 05/10/2017 | Q1 | -- | $433.2M | $0.41 | -- | -- |
| 02/24/2017 | Q4 | -- | $475.8M | $0.40 | -- | -- |
| 11/08/2016 | Q3 | -- | $460M | $0.39 | -- | -- |
| 08/09/2016 | Q2 | -- | $442.7M | $0.60 | -- | -- |
| 05/10/2016 | Q1 | -- | $432M | $0.54 | -- | -- |
| 02/24/2016 | Q4 | -- | $790.6M | $0.71 | -- | -- |
EchoStar Corp. reported $3.6B worth of top line sales in its most recent quarter.
EchoStar Corp. announced earnings per share of -$44.37 which represents a miss of analyst forecast a -$1.22 per share.
EchoStar Corp. reported $480.1M that represents $1.67 per share over the last quarter.
EchoStar Corp.'s earnings are forecast to decrease from -$0.44 per share to -$2.02 per share next year representing a decrease of -6908.43%.
EchoStar Corp.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.